Ascendis Pharma A/S (ASND) Stock Forecast & Price Target
$16.60B
Market Cap
—
P/E
—
Forward P/E
—
Score
ASND price $252.24 +2.69 +1.08%
ASND fair value $186.73. Price $252.24. Price is 35% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | 0.91 | — | 412.31M |
| 2026-08-13 | 3.29 | 1.71 | 387.48M | 376.75M |
| 2026-05-07 | 0.32 | 0.19 | 284.92M | 308.93M |
| 2026-02-11 | -0.64 | -0.06 | 344.84M | 292.26M |
| 2025-11-12 | -1.17 | -0.41 | 250.22M | 302.60M |
| 2025-08-07 | -0.93 | -1.42 | 186.09M | 233.12M |
| 2025-05-01 | -1.66 | -1.56 | 110.67M | 153.48M |
| 2025-02-12 | -0.68 | -1.20 | 180.09M | 125.42M |
| 2024-11-14 | -1.81 | -1.83 | 63.43M | 74.14M |
| 2024-09-03 | -2.05 | -1.54 | 38.71M | 37.58M |
| 2024-05-02 | -2.48 | -1.62 | 103.02M | 92.36M |
| 2024-02-07 | -1.66 | -2.19 | 151.44M | 111.12M |
| 2023-11-07 | -3.08 | -2.55 | 50.67M | 55.32M |
| 2023-09-05 | -2.35 | -2.68 | 55.40M | 43.53M |
| 2023-04-27 | -2.18 | -2.93 | 36.52M | 25.78M |
| 2023-02-16 | -3.96 | -2.74 | 24.66M | 22.05M |
| 2022-11-02 | -3.05 | -2.52 | 14.93M | 13.60M |
| 2022-08-10 | -1.50 | -2.19 | 6.44M | 6.01M |
| 2022-05-11 | -2.31 | -2.09 | 7.55M | 5.25M |
| 2022-03-02 | -2.06 | -2.57 | 5.55M | 3.38M |
| 2021-11-10 | -1.69 | -2.63 | 1.29M | 1.70M |
| 2021-08-25 | -3.01 | -2.75 | 1.21M | 1.30M |
| 2021-05-27 | -1.43 | -2.09 | 877.43K | 1.19M |
| 2021-03-10 | -3.15 | -1.84 | 656.11K | 2.07M |
| 2020-11-11 | -2.73 | -1.87 | 3.24M | 2.84M |
| 2020-08-27 | -2.34 | -1.71 | 1.62M | 1.24M |
| 2020-05-19 | -1.44 | -1.48 | 2.42M | 2.49M |
| 2020-04-01 | -1.85 | -1.59 | 2.84M | 2.08M |
| 2019-11-18 | -0.59 | -1.32 | 2.46M | 5.57M |
| 2019-08-28 | -1.38 | -1.34 | 3.65M | 3.43M |
| 2019-05-30 | -1.38 | -1.12 | 6.08M | 4.87M |
| 2019-04-03 | -0.85 | -1.12 | 12.56M | 8.00M |
| 2018-11-28 | -0.92 | -1.21 | 23.32K | 29.99K |
| 2018-08-29 | -0.64 | -1.05 | 20.89K | 29.15K |
| 2018-05-30 | -1.25 | -0.90 | 34.50K | 29.88K |
| 2018-03-28 | -1.13 | -0.99 | 328.53K | — |
| 2017-11-16 | -1.22 | -0.87 | 511.01K | 485.16K |
| 2017-08-18 | -1.10 | -0.85 | 505.97K | 362.34K |
| 2017-05-23 | -0.93 | -0.84 | 398.43K | 348.02K |
| 2017-03-22 | -0.55 | -0.61 | 1.09M | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Bodenhoff Mads | Buy | 3.00K | $110.00 | 330.00K |
| 2026-09-08 | Bodenhoff Mads | Sell | 3.00K | $110.00 | 330.00K |
| 2026-09-08 | Bodenhoff Mads | Sell | 3.00K | $270.19 | 810.57K |
| 2026-09-02 | HOLTUG LARS | Sell | 236 | $264.13 | 62.33K |
| 2026-08-14 | BIENAIME JEAN JACQUES | Buy | 900 | $246.91 | 222.22K |
| 2026-08-14 | BIENAIME JEAN JACQUES | Buy | 1.10K | $245.85 | 270.44K |
| 2026-06-02 | SMITH SCOTT THOMAS | Buy | 100 | $219.00 | 21.90K |
| 2026-05-29 | BIENAIME JEAN JACQUES | Buy | 100 | $223.50 | 22.35K |
| 2026-05-29 | BIENAIME JEAN JACQUES | Buy | 200 | $222.30 | 44.46K |
| 2026-05-29 | BIENAIME JEAN JACQUES | Buy | 200 | $223.76 | 44.75K |
| 2026-05-29 | SMITH SCOTT THOMAS | Buy | 250 | $223.32 | 55.83K |
| 2026-05-26 | BIENAIME JEAN JACQUES | Buy | 200 | $239.37 | 47.87K |
| 2026-05-26 | BIENAIME JEAN JACQUES | Buy | 200 | $236.24 | 47.25K |
| 2026-05-11 | JENSEN FLEMMING STEEN | Sell | 19.46K | $238.49 | 4.64M |
| 2026-04-14 | BIENAIME JEAN JACQUES | Buy | 9.16K | $249.84 | 2.29M |
| 2026-04-14 | BIENAIME JEAN JACQUES | Sell | 9.16K | $172.35 | 1.58M |
| 2026-03-23 | BIENAIME JEAN JACQUES | Other | 0 | — | — |
| 2026-03-23 | BIENAIME JEAN JACQUES | Other | 9.16K | $172.35 | 1.58M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 0 | — | — |
| 2026-03-18 | Fairey William | Other | 0 | — | — |
| 2026-03-18 | Fairey William | Other | 9.16K | $102.70 | 940.73K |
| 2026-03-18 | Fairey William | Other | 1.93K | — | — |
| 2026-03-18 | IMANI SIHAM | Other | 0 | — | — |
| 2026-03-18 | IMANI SIHAM | Other | 9.16K | $102.70 | 940.73K |
| 2026-03-18 | IMANI SIHAM | Other | 1.93K | — | — |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 0 | — | — |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 45.00K | $37.18 | 1.67M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 45.00K | $62.17 | 2.80M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 9.55K | — | — |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 30.00K | $62.17 | 1.87M |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 9.55K | — | — |
| 2026-03-18 | Bodenhoff Mads | Other | 30.00K | $124.52 | 3.74M |
| 2026-03-18 | Bodenhoff Mads | Other | 3.12K | $139.65 | 435.29K |
| 2026-03-18 | Bodenhoff Mads | Other | 3.69K | $110.00 | 405.57K |
| 2026-03-18 | Bodenhoff Mads | Other | 2.77K | — | — |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 0 | — | — |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 20.00K | $37.18 | 743.60K |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 45.00K | $62.17 | 2.80M |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 9.55K | — | — |
| 2026-03-18 | Morrison Lisa | Other | 0 | — | — |
| 2026-03-18 | Morrison Lisa | Other | 5.11K | $22.76 | 116.19K |
| 2026-03-18 | Morrison Lisa | Other | 5.00K | $37.18 | 185.90K |
| 2026-03-18 | Morrison Lisa | Other | 13.00K | $62.17 | 808.21K |
| 2026-03-18 | Morrison Lisa | Other | 7.50K | $108.00 | 810.00K |
| 2026-03-18 | Morrison Lisa | Other | 6.42K | $176.28 | 1.13M |
| 2026-03-18 | Morrison Lisa | Other | 3.05K | $139.65 | 426.35K |
| 2026-03-18 | Morrison Lisa | Other | 1.93K | — | — |
| 2026-03-18 | HOLTUG LARS | Other | 0 | — | — |
| 2026-03-18 | HOLTUG LARS | Other | 35.00K | $61.00 | 2.13M |
| 2026-03-18 | HOLTUG LARS | Other | 7.50K | $108.00 | 810.00K |
| 2026-03-18 | HOLTUG LARS | Other | 6.42K | $176.28 | 1.13M |
| 2026-03-18 | HOLTUG LARS | Other | 3.05K | $139.65 | 426.35K |
| 2026-03-18 | HOLTUG LARS | Other | 1.93K | — | — |
| 2026-03-18 | SPROGOE KENNETT | Other | 0 | — | — |
| 2026-03-18 | SPROGOE KENNETT | Other | 0 | — | — |
| 2026-03-18 | SPROGOE KENNETT | Other | 5.31K | $37.18 | 197.54K |
| 2026-03-18 | SPROGOE KENNETT | Other | 45.00K | $62.17 | 2.80M |
| 2026-03-18 | SPROGOE KENNETT | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | SPROGOE KENNETT | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | SPROGOE KENNETT | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | SPROGOE KENNETT | Other | 9.55K | — | — |
| 2026-03-18 | Wu Jay Donovan | Other | 0 | — | — |
| 2026-03-18 | Wu Jay Donovan | Other | 45.08K | $131.57 | 5.93M |
| 2026-03-18 | Wu Jay Donovan | Other | 9.55K | — | — |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 0 | — | — |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 0 | — | — |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 200.00K | $37.18 | 7.44M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 200.00K | $62.17 | 12.43M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 120.00K | $108.00 | 12.96M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 101.14K | $176.28 | 17.83M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 69.47K | $139.65 | 9.70M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 28.95K | — | — |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 0 | — | — |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 20.00K | $62.17 | 1.24M |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 9.55K | — | — |
| 2026-03-18 | Cha Albert | Other | 0 | — | — |
| 2026-03-18 | Cha Albert | Other | 542 | $62.17 | 33.70K |
| 2026-03-18 | Cha Albert | Other | 7.50K | $108.00 | 810.00K |
| 2026-03-18 | Cha Albert | Other | 6.42K | $176.28 | 1.13M |
| 2026-03-18 | Cha Albert | Other | 3.05K | $139.65 | 426.35K |
| 2026-03-18 | Cha Albert | Other | 1.93K | — | — |
| 2026-03-18 | Shu Aimee | Other | 0 | — | — |
| 2026-03-18 | Shu Aimee | Other | 9.55K | — | — |
| 2008-12-18 | Trinad Capital Master Fund Ltd. | Buy | 1.06M | $797,876.00 | 848.81B |
| 2008-12-18 | Wolf Jay | Buy | 1.06M | $797,876.00 | 848.81B |
| 2008-12-18 | ELLIN ROBERT S | Buy | 1.06M | $797,876.00 | 848.81B |
| 2008-12-02 | SCHWARTZ JEFFREY A | Buy | 1.80M | $1.25 | 2.25M |
| 2008-12-02 | SCHWARTZ JEFFREY A | Other | 0 | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 334, holders +43 vs prior quarter. Ownership 104.00%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.28M | 0 | 0.00% | 2.74B |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 6.75M | 6.75M | New | 1.80B |
| AVORO CAPITAL ADVISORS LLC | 5.11M | 48.61K | +0.96% | 1.36B |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4.80M | -15.17K | -0.32% | 1.28B |
| JUPITER TOPCO LLC | 3.65M | 3.65M | New | 973.38M |
| FMR LLC | 3.55M | -331.03K | -8.54% | 945.68M |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.63M | -596.16K | -18.46% | 702.55M |
| BLACKROCK, INC. | 2.21M | 1.55M | +234.59% | 589.94M |
| CAPITAL INTERNATIONAL INVESTORS | 1.99M | 29.77K | +1.52% | 530.40M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.88M | 14.63K | +0.79% | 500.14M |
| FRANKLIN TEMPLETON INC | 1.86M | -189.44K | -9.23% | 496.77M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.55M | -209.00K | -11.89% | 413.05M |
| AMERICAN CENTURY COMPANIES INC | 1.40M | 3.46K | +0.25% | 373.56M |
| PERCEPTIVE ADVISORS LLC | 1.16M | -367.70K | -24.01% | 310.39M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.12M | 1.12M | New | 299.40M |
| CAPITAL WORLD INVESTORS | 906.08K | 5.56K | +0.62% | 241.67M |
| PRINCIPAL FINANCIAL GROUP INC | 873.50K | -22.89K | -2.55% | 232.98M |
| POLAR CAPITAL HOLDINGS PLC | 616.91K | -34.80K | -5.34% | 164.54M |
| GOLDMAN SACHS GROUP INC | 559.53K | -6.66K | -1.18% | 149.24M |
| MORGAN STANLEY | 544.39K | -61.95K | -10.22% | 145.20M |
| STATE STREET CORP | 513.97K | 426.63K | +488.51% | 137.09M |
| INVESCO LTD. | 414.20K | 52.09K | +14.38% | 110.47M |
| GEODE CAPITAL MANAGEMENT, LLC | 403.15K | 330.21K | +452.71% | 107.53M |
| UBS GROUP AG | 401.88K | 194.54K | +93.83% | 107.19M |
| ALLIANCEBERNSTEIN L.P. | 399.29K | 121.09K | +43.53% | 106.50M |
Insights · Dividends · Forecast · Financials · Learn
The Ascendis Pharma A/S (ASND) forecast collects the published price target, analyst ratings, and earnings estimates when they are available.
Forecasts are third-party estimates and often wrong. They are not investment advice.
A low, average, and high target are shown in the tool when analysts have published them.
A Buy, Hold, and Sell split is shown when analysts have published ratings. It is not a recommendation.
EPS and revenue estimates for the coming years are drawn in the chart when analysts have published them.
The Stocklytics Score, when it is published for ASND, averages value, quality, and growth on a 0–100 scale. It is not a price target. Fair value is a separate estimate on the fair value tab.
A 12-month average target is shown on this page when analysts have published one.
A consensus is shown when analysts have published ratings. It is not a recommendation.
An EPS estimate for 2026 is shown in the chart on this page when analysts have published one.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Ascendis Pharma A/S · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$16.60B
Market Cap
—
P/E
—
Forward P/E
—
Score